BNP PARIBAS FINANCIAL MARKETS - ACURA PHARMACEUTICALS INC ownership

ACURA PHARMACEUTICALS INC's ticker is ACUR and the CUSIP is 00509L703. A total of 38 filers reported holding ACURA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ACURA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$78,000
-21.2%
720.0%0.00%
Q1 2014$99,000
-17.5%
720.0%0.00%
Q4 2013$120,000720.00%
Other shareholders
ACURA PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 10,284,886$4,402,0001.37%
FAS Wealth Partners, Inc. 81,983$37,0000.02%
Lincoln Capital LLC 21,000$9,0000.01%
ROTHSCHILD INVESTMENT LLC /IL 100,000$45,0000.01%
INTRUST BANK NA 23,960$11,0000.00%
Mariner, LLC 41,993$19,0000.00%
CORTLAND ASSOCIATES INC/MO 21,550$10,0000.00%
Spark Investment Management LLC 11,200$5,0000.00%
VANGUARD GROUP INC 933,064$420,0000.00%
THOMPSON DAVIS & CO., INC. 32$00.00%
View complete list of ACURA PHARMACEUTICALS INC shareholders